DeepChek® NGS ecosystem maps viral resistance mutations to next-generation therapies, unlocking new insights for monitoring immunocompromised patient cohorts. WOIPPY ...
Key challenges to developing "trans-tumor" targeted therapies are outlined in an editorial in the New England Journal of Medicine published Thursday by Fabrice André, head of the predictive biomarkers ...
Please provide your email address to receive an email when new articles are posted on . Nearly half of people diagnosed with advanced cancer between 2018 and 2022 did not undergo next-generation ...
International HIV publication further validates the DeepChek® brand for HIV genotyping and long- & short-read NGS, ...
Key growth drivers include technological advancements, reduced sequencing costs, and increased interest from academia and pharmaceuticalsDublin, April 20, 2026 (GLOBE NEWSWIRE) -- The "Single Cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results